You are here

breast cancer

Aveo Oncology to end breast cancer study due to low enrollment

Yahoo/Reuters

Thu, 01/30/14 - 10:07 am

clinical trials

Biocon to start selling breast cancer drug in India in February

Yahoo/Reuters

Sat, 01/18/14 - 11:21 am

Myriad Genetics: How Low Can It Go?

Barron's

Mon, 12/30/13 - 11:37 am

Myriad Genetics

AstraZeneca’s Arimidex Halves Breast Cancer Risk, Study Finds

Bloomberg

Tue, 12/17/13 - 08:57 am

Arno Therapeutics to Present Data on Two Potential Predictive Biomarkers at the San Antonio Breast Cancer Symposium 2013

Yahoo/Globe Newswire

Sat, 12/14/13 - 11:54 am

Arno Therapeutics

PAM50-Based Prosigna Breast Cancer Assay Helps to Identify Patients at Risk of Late Distant Recurrence in a Combined Analysis of 2,137 Patients

Yahoo/BusinessWire

Sat, 12/14/13 - 11:50 am

Prosigna Breast Cancer Prognostic Gene Signature Assay

NanoString Technologies

Breast Cancer Drug Data Boosts Puma Biotechnology

Investors.com

Thu, 12/5/13 - 12:01 pm

Puma Biotechnology

Bristol-Myers Squibb

Pfizer Feels the Heat From Novartis

Wall St Cheat Sheet

Sat, 11/23/13 - 12:45 pm

Novartis chases Pfizer in hot new breast cancer drug area

Yahoo/Reuters

Fri, 11/22/13 - 10:27 am

EU backs Roche’s Kadycla in breast cancer

PM Live

Wed, 11/20/13 - 08:33 am

FDA puts a clamp on Curis cancer drug program after patient dies of liver failure

Fierce Biotech

Wed, 11/6/13 - 10:38 am

Pfizer Vs. Novartis: A New Era In Breast Cancer Treatment

Seeking Alpha

Thu, 10/31/13 - 09:38 am

ImmunoGen, Inc. Announces SAR566658 Clinical Findings Reported at AACR-NCI-EORTC Conference

Yahoo/BusinessWire

Sun, 10/20/13 - 02:37 pm

Quest Introduces Breast-Cancer Gene Test Rivaling Myriad

Bloomberg

Wed, 10/16/13 - 08:32 am

Quest Diagnostics

Myriad Genetics

Endocyte falls after panel says cancer drug isn't working better than older treatment in study

Yahoo/AP

Fri, 10/11/13 - 11:44 am

Myriad Genetics Changes How Doctors Treat Patients

Motley Fool

Mon, 10/7/13 - 07:27 pm

Myriad Genetics

Roche breast cancer drug gets expanded U.S. pre-surgery approval

Reuters

Mon, 09/30/13 - 12:01 pm

BioMarin Provides Updated Phase 1/2 Data on BMN 673 in Breast Cancer at the European Cancer Congress 2013

Yahoo/GlobeNewsWire

Sun, 09/29/13 - 01:33 pm

Arno Therapeutics to Present Data Validating Target Biomarker at European Cancer Congress 2013

Yahoo/Globe Newswire

Sat, 09/28/13 - 12:10 pm

Arno Therapeutics

ImmunoGen, Inc. Announces Results from Kadcyla® Phase III Trial, TH3RESA, Being Presented Today at the European Cancer Congress

Yahoo/BusinessWire

Sat, 09/28/13 - 11:58 am

Pages